Mabnus Biotech is committed to addressing challenges in the industry related to the development of functional active proteins and high-quality, high-throughput antibodies. Leveraging two core platforms: the mammalian cell protein expression platform and the B-cell antibody development platform, the company is dedicated to providing one-stop antibody development services to scientific research institutions, diagnostic and pharmaceutical companies.